Children born to mothers with autoimmune diseases during pregnancy face a 57% higher risk of developing type 1 diabetes, according to a Swedish registry cohort study published in JAMA Pediatrics.
Swedish Registry Data Links Parental Autoimmune Conditions to Offspring Diabetes Risk
The analysis examined nearly 1.5 million individuals born in Sweden between 2001 and 2014, tracking health outcomes through 2023. Xingbo Mo, PhD, of Karolinska Institutet in Stockholm, and colleagues found that paternal autoimmune disease before childbirth carried a comparable association, increasing offspring risk by an adjusted HR of 1.51. The median age of the children during the follow-up period was 15.3 years, and 51.4% of the cohort were male.
When researchers narrowed the focus to parents with type 1 diabetes specifically, the risk escalated sharply. Maternal type 1 diabetes was linked with a more than fourfold increase in risk for offspring, while paternal type 1 diabetes was associated with an even higher hazard ratio of 5.79. The study authors noted a clear gradient in susceptibility, with the highest risk appearing in children who had both parents affected by the condition.
Specific Autoimmune Categories Reveal Maternal and Paternal Variations
While composite estimates for overall autoimmune disease showed no overall difference between mothers and fathers, specific disease categories demonstrated distinct patterns. Paternal associations proved stronger for endocrine conditions, particularly autoimmune thyroiditis. In contrast, maternal associations showed greater strength for ankylosing spondylitis and gastrointestinal autoimmune disorders.
Benjamin Nwosu, MD, of Northwell Health Cohen Children’s Medical Center in New York, pointed out that 40 to 50% of the risk for type 1 diabetes is carried on major histocompatibility complex class 2 genes. Nwosu, who was not involved with the study, explained that type 1 diabetes stems from a polygenic aggregation of genes rather than a Mendelian autosomal dominant pattern. He also cautioned that the findings from Sweden, a region where type 1 diabetes is almost endemic, might not translate entirely to other global populations.
Clinical Screening Recommendations for At-Risk Children
In an accompanying editorial, Mikael Knip, MD, PhD, of Biomedicum Helsinki in Finland, emphasized that children with a familial history represent a definite risk group. He noted that published consensus guidelines exist for screening and monitoring individuals at risk for type 1 diabetes, though implementation varies based on available resources.
Nwosu added that standard clinical practice already involves screening pediatric type 1 diabetes patients for celiac disease and autoimmune thyroid conditions due to known clustering risks. The research team acknowledged several limitations in the registry data, including a lack of information regarding clinical disease severity, autoantibody levels, disease activity during pregnancy, or medication use.
Common Questions About Familial Autoimmune Transmission
How much does maternal type 1 diabetes increase offspring risk?
Maternal type 1 diabetes is linked with a more than fourfold increase in the risk of type 1 diabetes in children, according to the Karolinska Institutet study data.
Did paternal autoimmune diseases show a similar association?
Yes. Paternal autoimmune disease present before childbirth was associated with a higher risk of type 1 diabetes in offspring, comparable to the maternal association.
What specific conditions showed stronger paternal links?
Paternal associations were stronger for endocrine conditions, most notably autoimmune thyroiditis, while maternal associations were stronger for ankylosing spondylitis and gastrointestinal disorders.
What limitations did the study authors note?
The registry analysis did not account for disease severity, autoantibody levels, disease activity during pregnancy, or medication use among the parents.
Keep reading